-
公开(公告)号:US07189851B2
公开(公告)日:2007-03-13
申请号:US10507006
申请日:2003-02-24
申请人: Ashok Bhandari , Eric Eugene Boros , David John Cowan , Anthony Louis Handlon , Clifton Earl Hyman , Jeffrey Alan Oplinger , Michael Howard Rabinowitz , Philip Stewart Turnbull
发明人: Ashok Bhandari , Eric Eugene Boros , David John Cowan , Anthony Louis Handlon , Clifton Earl Hyman , Jeffrey Alan Oplinger , Michael Howard Rabinowitz , Philip Stewart Turnbull
IPC分类号: C07D471/00 , C07D491/00 , C07D498/00 , C07D513/00 , C07D515/00
CPC分类号: C07D471/14 , C07D487/04
摘要: The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions.
摘要翻译: 本发明涉及新颖的稠合杂环体系化合物及其用于治疗和预防疾病或病症的方法。
-
公开(公告)号:US07645771B2
公开(公告)日:2010-01-12
申请号:US10538144
申请日:2003-12-12
申请人: Wieslaw Mieczyslaw Kazmierski , Chrisopher Joseph Aquino , Neil Bifulco , Eric Eugene Boros , Brian Andrew Chauder , Pek Yoke Chong , Maosheng Duan , Felix Deanda, Jr. , Cecilia Suarez Koble , Ed Williams McLean , Jennifer Poole Peckham , Angilique C Perkins , James Benjamin Thompson , Dana Vanderwall
发明人: Wieslaw Mieczyslaw Kazmierski , Chrisopher Joseph Aquino , Neil Bifulco , Eric Eugene Boros , Brian Andrew Chauder , Pek Yoke Chong , Maosheng Duan , Felix Deanda, Jr. , Cecilia Suarez Koble , Ed Williams McLean , Jennifer Poole Peckham , Angilique C Perkins , James Benjamin Thompson , Dana Vanderwall
IPC分类号: A61K31/46
CPC分类号: C07D451/04
摘要: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的衍生物,其可用于治疗CCR5相关疾病和病症的预防,例如抑制HIV复制,预防或治疗HIV感染, 以及治疗所得的获得性免疫缺陷综合征(AIDS)。
-
公开(公告)号:US08691991B2
公开(公告)日:2014-04-08
申请号:US10597902
申请日:2005-02-10
申请人: Brian Alvin Johns , Eric Eugene Boros , Takshi Kawasuji , Cecilia S. Koble , Noriyuki Kurose , Hitoshi Murai , Ronald George Sherrill , Jason Gordon Weatherhead
发明人: Brian Alvin Johns , Eric Eugene Boros , Takshi Kawasuji , Cecilia S. Koble , Noriyuki Kurose , Hitoshi Murai , Ronald George Sherrill , Jason Gordon Weatherhead
IPC分类号: C07D471/04 , A61K31/4375
CPC分类号: C07D471/04
摘要: The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
摘要翻译: 本发明的特征在于是HIV整合酶抑制剂的化合物,因此可用于抑制HIV复制,预防和/或治疗HIV感染以及治疗AIDS和/或ARC。
-
公开(公告)号:US20100305207A1
公开(公告)日:2010-12-02
申请号:US12677846
申请日:2008-09-25
申请人: Pierette Banker , Eric Eugene Boros , Scott Howard Dickerson , Istvan Kaldor , Cecilia S. Koble , Michael Tolar Martin , Steven Meagher Sparks , Stephen Andrew Thomson
发明人: Pierette Banker , Eric Eugene Boros , Scott Howard Dickerson , Istvan Kaldor , Cecilia S. Koble , Michael Tolar Martin , Steven Meagher Sparks , Stephen Andrew Thomson
IPC分类号: A61K31/197 , C07C275/42 , A61P3/10 , A61P3/04 , A61P3/06 , A61P9/00
CPC分类号: C07C275/34 , C07C2601/02
摘要: This invention relates to a novel compound which is a glycogen phosphorylase inhibitor and its use in the treatment of diabetes and other conditions associated therewith. The invention further relates to a pharmaceutical composition containing the compound and to processes for preparing the compound and pharmaceutical composition.
-
5.
公开(公告)号:US06187789B1
公开(公告)日:2001-02-13
申请号:US09381719
申请日:2000-01-19
申请人: Eric Cleveland Bigham , Grady Evan Boswell , John Joseph Savarese , Roy Archibald Swaringen, Jr. , Sanjay Shashikant Patel , Eric Eugene Boros , Robert Anthony Mook, Jr. , Vincente Samano
发明人: Eric Cleveland Bigham , Grady Evan Boswell , John Joseph Savarese , Roy Archibald Swaringen, Jr. , Sanjay Shashikant Patel , Eric Eugene Boros , Robert Anthony Mook, Jr. , Vincente Samano
IPC分类号: A61K3147
CPC分类号: C07D217/16 , C07D217/20
摘要: Ultrashort acting neuromuscular blocking agents of Formula (I) which are useful as skeletal muscle relaxants during emergency intubation procedures, routine surgery and post-operative settings are disclosed, wherein: X is a halogen; h is from 1 to 2; Y is hydrogen or methoxy; Z1 and Z2 are methyl; W1 and W2 are carbon; and A is a pharmaceutically acceptable anion.
摘要翻译: 公开了在紧急插管程序,常规手术和术后设置中可用作骨骼肌松弛剂的式(I)的超短促作用神经肌肉阻滞剂,其中:X为卤素; h为1〜2; Y是氢或甲氧基; Z1和Z2是甲基; W1和W2是碳; A是药学上可接受的阴离子。
-
公开(公告)号:US08222261B2
公开(公告)日:2012-07-17
申请号:US12373524
申请日:2009-01-13
申请人: Subba R Katamreddy , Richard Dama Caldwell , Dennis Heyer , Vincente Samano , James Benjamin Thompson , Andrew J Carpenter , Christopher R Conlee , Eric Eugene Boros , Brian D Thompson
发明人: Subba R Katamreddy , Richard Dama Caldwell , Dennis Heyer , Vincente Samano , James Benjamin Thompson , Andrew J Carpenter , Christopher R Conlee , Eric Eugene Boros , Brian D Thompson
IPC分类号: A61K31/519
CPC分类号: C07D487/04 , A61K31/404 , A61K31/495 , A61K31/519 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14 , C07F9/65583
摘要: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
摘要翻译: 本发明涉及可用于治疗代谢紊乱,特别是II型糖尿病和相关病症的新型化合物,以及制备和使用这些化合物的方法。
-
7.
公开(公告)号:US06177445B1
公开(公告)日:2001-01-23
申请号:US09381721
申请日:1999-12-22
申请人: Eric Cleveland Bigham , Grady Evan Boswell , John Joseph Savarese , Roy Archibald Swaringen, Jr. , Sanjay Shashikant Patel , Eric Eugene Boros , Robert Anthony Mook, Jr. , Vincente Samano
发明人: Eric Cleveland Bigham , Grady Evan Boswell , John Joseph Savarese , Roy Archibald Swaringen, Jr. , Sanjay Shashikant Patel , Eric Eugene Boros , Robert Anthony Mook, Jr. , Vincente Samano
IPC分类号: A61K3147
CPC分类号: C07D217/16 , C07D217/20
摘要: Ultra short acting neuromuscular blocking agents of Formula (I) which are useful as skeletal muscle relaxants during emergency intubation procedures, routine surgery and post-operative settings are disclosed, wherein q and t are independently from 0 to 4; X1 and X2 are independently halogen; ha and hb are independenity from 0 to 2; Z1 and Z2 are indepentdently hydrogen, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl with the proviso that Z1 and Z2 are not both hydrogen; Y1, Y2, and Y3 and Y4 are independently hydrogen, halogen or C1-3 alkoxy; m and p are independently 1 to 6; n and r are independently 0 to 4; with the proviso the if ha and hb are both 0, then r is 0 and n is 0 to 2; R1 to R14 are independently hydrogen, halogen, C1-3 alkoxy, or R2 and R3 together with the carbon atoms to which they are bonded, R5 and R6 together with the carbon atoms to which they are bonded, R9 and R10 together with the carbon atoms to which they are bonded, R12 and R13 together with the carbon atoms to which they are bonded, may independently form a methylenedioxy or ethylenedioxy moiety contained in five- or six-membered ring; W1 and W2 are carbon; and A is a pharmaceutically acceptable anion.
摘要翻译: 公开了在紧急插管程序,常规手术和术后设置中可用作骨骼肌松弛剂的式(I)的超短效神经肌肉阻滞剂,其中q和t独立地为0至4; X1和X2独立地为卤素; ha和hb是从0到2的独立性; Z1和Z2独立地为氢,C1-6烷基,C2-6烯基或C2-6炔基,条件是Z1和Z2不同时为氢; Y1,Y2和Y3和Y4独立地是氢,卤素或C1-3烷氧基; m和p独立地为1至6; n和r分别为0〜4; 条件是如果ha和hb均为0,则r为0且n为0至2; R 1至R 14独立地为氢,卤素,C 1-3烷氧基或R 2和R 3与它们所键合的碳原子一起,R 5和R 6与它们所键合的碳原子一起,R 9和R 10与碳 R12和R13与它们所键合的碳原子一起可以独立地形成五元或六元环中所含的亚甲二氧基或亚乙二氧基部分; W1和W2是碳; A是药学上可接受的阴离子。
-
-
-
-
-
-